I’m on the steering committee of Fed Up, a coalition of medical professionals and addiction specialists working to end the opioid addiction epidemic. Incensed that the US FDA approved Zohydro ER, a high-dose, single-entity hydrocodone formulation, this group wrote a letter to the FDA Commissioner Dr. Margaret Hamburg. By approving this drug, the FDA has put pharmaceutical industry interests ahead of public online julietta casino health.
In an ABC News report, experts talk about this drug as the “Drug Dealer’s Dream.” It lacks a protective coating and is high potency. Could it be that Zohydro is “purposefully easy to abuse,” as some suggest?
Zohydro will lead to more overdose deaths.
James Kennedy, who I referenced in my book, How to Prevent, Detect, Treat & Live With the Addict Among Us, and interviewed on my radio show, Afflicted by Addiction, which you can hear here, is interviewed in the ABC news report, and re-tells the story of how his son’s “friends” dumped him face-down along a highway when he was overdosing on Xanex and other opioids. (On a positive note, his willingness to tell this story was instrumental in bringing attention to and passing the 911-good samaritan law.)
Adding more easy-to-abuse opioids onto the street will only exacerbate the problem.
Along with fellow Fed Up Steering Committee members G. Caleb Alexander of Johns Hopkins Center for Drug and Safety Awareness and Stuart Gitlow, MD, of the American Society of Addiction Medicine, I will continue to battle the FDA’s approval of Zohydro.